Branch retinal vein occlusion: Clinical findings, natural history, and management

Comprehensive Ophthalmology Update

Volumn 7, Issue 6, 2006, Pages 265-276

  Margolis, Ron ^a   Singh, Rishi P ^a   Kaiser, Peter K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Branch retinal vein occlusion; Laser photocoagulation; Macular edema; Sheathotomy; Triamcinolone acetonide; Vitrectomy

Indexed keywords

BERAPROST; BEVACIZUMAB; DEXAMETHASONE; FLUOCINOLONE ACETONIDE; PEGAPTANIB; RANIBIZUMAB; STEROID; TICLOPIDINE; TRIAMCINOLONE ACETONIDE; GLUCOCORTICOID;

BRANCH RETINAL ARTERY OCCLUSION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EYE SURGERY; HEMODILUTION; HUMAN; IMPLANT; LASER COAGULATION; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; RETINA EXUDATE; RETINA HEMORRHAGE; RETINA ISCHEMIA; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; REVIEW; RISK FACTOR; SHEATHOTOMY; VEIN ANASTOMOSIS; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS HEMORRHAGE; DELAYED RELEASE FORMULATION; FLUORESCENCE ANGIOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; RETINA VEIN OCCLUSION;

DELAYED-ACTION PREPARATIONS; FLUORESCEIN ANGIOGRAPHY; GLUCOCORTICOIDS; HUMANS; LASER COAGULATION; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE;

EID: 33947539348     PISSN: 15277313     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)

1. _: Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 98: 271-82, 1984
2. Klein R, Klein BE, Moss SE, et al: The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98: 133-41; discussion 141-3, 2000
3. Mitchell P, Smith W, Chang A: Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 114: 1243-7, 1996
4. _: Risk factors for branch retinal vein occlusion. The Eye Disease Case-control Study Group. Am J Ophthalmol 116: 286-96, 1993
5. Gutman FA, Zegarra H: The natural course of temporal retinal branch vein occlusion. Trans Am Acad Ophthalmol Otolaryngol 78: OP178-92, 1974
6. Feist RM, Ticho BH, Shapiro MJ, et al: Branch retinal vein occlusion and quadratic variation in arteriovenous crossings. Am J Ophthalmol 113: 664-8, 1992
7. Zhao J, Sastry SM, Sperduto RD, et al: Arteriovenous crossing patterns in branch retinal vein occlusion. The Eye Disease Case-Control Study Group. Ophthalmology 100: 423-8, 1993
8. Staurenghi G, Lonati C, Aschero M, et al: Arteriovenous crossing as a risk factor in branch retinal vein occlusion. Am J Ophthalmol 117: 211-3, 1994
9. Weinberg D: Arteriovenous crossing as a risk factor in branch retinal vein occlusion. Am J Ophthalmol 118: 263-5, 1994
10. Joffe L, Goldberg RE, Magargal LE, et al: Macular branch vein occlusion. Ophthalmology 87: 91-8, 1980
11. Finkelstein D, Kimball A: Risk factors of branch retinal vein occlusion. Arch Ophthalmol 104: 795, 1986
12. Kumar B, Yu DY, Morgan WH, et al: The distribution of angio-architectural changes within the vicinity of the arteriovenous crossing in branch retinal vein occlusion. Ophthalmology 105: 424-7, 1998
13. Battaglia PM: Hyperfluorescence at arteriovenous crossing before branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240: 67; author reply 68, 2002
14. Cousins SW, Flynn HW, Clarkson JG: Macroaneurysms associated with retinal branch vein occlusion. Am J Ophthalmol 109: 567-70, 1990
15. Parodi MB, Da Pozzo S, Saviano S, et al: Branch retinal vein occlusion and macroaneurysms. Int Ophthalmol 21: 161-4, 1997
16. Finkelstein D: Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol 110: 1427-34, 1992
17. Gutman FA: Macular edema in branch retinal vein occlusion: prognosis and management. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 83: 488-95, 1977
18. Michels RG, Gass JD: The natural course of retinal branch vein obstruction. Trans Am Acad Ophthalmol Otolaryngol 78: OP166-77, 1974
19. Battaglia Parodi M, Saviano S, Ravalico G: Grid laser treatment in macular branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 237: 1024-7, 1999
20. Silva RM, Faria de Abreu JR, Cunha-Vaz JG: Blood-retina barrier in acute retinal branch vein occlusion. Graefes Arch Clin Exp Ophthalmol 233: 721-6, 1995
21. Noma H, Minamoto A, Funatsu H, et al: Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244: 309-15, 2005
22. Clemett RS, Kohner EM, Hamilton AM: The visual prognosis in retinal branch vein occlusion. Trans Ophthalmol Soc U K 93: 523-35, 1973
23. Shilling JS, Jones CA: Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular oedema. Br J Ophthalmol 68: 196-8, 1984 Joondeph HC, Joondeph BC: Posterior tractional retinal breaks complicating branch retinal vein occlusion. Retina 8: 136-40, 1988
24. Spaide RF, Lee JK, Klancnik JK, et al: Optical coherence tomography of branch retinal vein occlusion. Retina 23: 343-7, 2003
25. Hayreh SS, Rojas P, Podhajsky P, et al: Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 90: 488-506, 1983
26. _: Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. Arch Ophthalmol 104: 34-41, 1986
27. Finkelstein D, Clarkson J, Diddie K, et al: Branch vein occlusion. Retinal neovascularization outside the involved segment. Ophthalmology 89: 1357-61, 1982
28. Kado M, Trempe CL: Role of the vitreous in branch retinal vein occlusion. Am J Ophthalmol 105: 20-4, 1988
29. Rabinowicz IM, Litman S, Michaelson IC: Branch venous thrombosis - a pathological report. Trans Ophthalmol Soc U K 88: 191-210, 1969
30. Duker JS, Brown GC: Anterior location of the crossing artery in branch retinal vein obstruction. Arch Ophthalmol 107: 998-1000, 1989
31. Jefferies P, Clemett R, Day T: An anatomical study of retinal arteriovenous crossings and their role in the pathogenesis of retinal branch vein occlusions. Aust N Z J Ophthalmol 21: 213-7, 1993
32. Kumar B, Yu DY, Morgan WH, et al: The distribution of angio-architectural changes within the vicinity of the arteriovenous crossing in branch retinal vein occlusion. Ophthalmology 105: 424-7, 1998
33. Christoffersen NL, Larsen M: Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology 106: 2054-62, 1999
34. Frangieh GT, Green WR, Barraquer-Somers E, et al: Histopathologic study of nine branch retinal vein occlusions. Arch Ophthalmol 100: 1132-40, 1982
35. Bowers DK, Finkelstein D, Wolff SM, et al: Branch retinal vein occlusion. A clinicopathologic case report. Retina 7: 252-9, 1987
36. Pournaras CJ, Tsacopoulos M, Strommer K, et al: Experimental retinal branch vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy. Ophthalmology 97: 1321-8, 1990
37. Peyman GA, Khoobehi B, Moshfeghi A, et al: Reversal of blood flow in experimental branch retinal vein occlusion. Ophthalmic Surg Lasers 29: 595-7, 1998
38. Ben-Nun J: Capillary blood flow in acute branch retinal vein occlusion. Retina 21: 509-12, 2001
39. Genevois O, Paques M, Simonutti M, et al: Microvascular remodeling after occlusion-recanalization of a branch retinal vein in rats. Invest Ophthalmol Vis Sci 45: 594-600, 2004
40. Donati G, Pournaras CJ, Pizzolato GP, et al: Decreased nitric oxide production accounts for secondary arteriolar constriction after retinal branch vein occlusion. Invest Ophthalmol Vis Sci 38: 1450-7, 1997
41. Avila CP, Bartsch DU, Bitner DG, et al: Retinal blood flow measurements in branch retinal vein occlusion using scanning laser Doppler flowmetry. Am J Ophthalmol 126: 683-90, 1998
42. Donati G, Pournaras CJ, Tsacopoulos M: Effect of nitroprusside on arteriolar constriction after retinal branch vein occlusion. Invest Ophthalmol Vis Sci 39: 1910-7, 1998
43. Hayreh SS, Zimmerman B, McCarthy MJ, et al: Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 131: 61-77, 2001
44. Martin SC, Butcher A, Martin N, et al: Cardiovascular risk assessment in patients with retinal vein occlusion. Br J Ophthalmol 86: 774-6, 2002
45. Johnston RL, Brucker AJ, Steinmann W, et al: Risk factors of branch retinal vein occlusion. Arch Ophthalmol 103: 1831-2, 1985
46. Appiah AP, Trempe CL: Differences in contributory factors among hemicentral, central, and branch retinal vein occlusions. Ophthalmology 96: 364-6, 1989
47. Cekiç O, Totan Y, Aydin E, et al: The role of axial length in central and branch retinal vein occlusion. Ophthalmic Surg Lasers 30: 523-7, 1999
48. Simons BD, Brucker AJ: Branch retinal vein occlusion. Axial length and other risk factors. Retina 17: 191-5, 1997
49. Timmerman EA, de Lavalette VW, van den Brom HJ: Axial length as a risk factor to branch retinal vein occlusion. Retina 17: 196-9, 1997
50. Weger M, Stanger O, Deutschmann H, et al: Hyperhomocyst(e)inemiaJ but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology 109: 1105-9, 2002
51. Remky A, Arend O, Jung F, et al: Haemorheology in patients with branch retinal vein occlusion with and without risk factors. Graefes Arch Clin Exp Ophthalmol 234 Suppl 1: S8-12, 1996
52. Kuhli C, Scharrer I, Koch F, et al: Factor XII deficiency: a thrombophilic risk factor for retinal vein occlusion. Am J Ophthalmol 137: 459-64, 2004
53. Kadayifçilar S, Ozatli D, Ozcebe O, et al: Is activated factor VII associated with retinal vein occlusion?. Br J Ophthalmol 85: 1174-8, 2001
54. Greiner K, Hafner G, Dick B, et al: Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol 128: 69-74, 1999
55. Banik S, Bhutto HU, Bagga P: Recurrent branch retinal vein occlusion with factor V leiden mutation. Eye 20: 948-9, 2006
56. Esrick E, Subramanian ML, Heier JS, et al: Multiple laser treatments for macular edema attributable to branch retinal vein occlusion. Am J Ophthalmol 139: 653-7, 2005
57. Maár N, Luksch A, Graebe A, et al: Effect of laser photocoagulation on the retinal vessel diameter in branch and macular vein occlusion. Arch Ophthalmol 122: 987-91, 2004
58. Ogata N, Tombran-Tink J, Jo N, et al: Upregulation of pigment epithelium-derived factor after laser photocoagulation. Am J Ophthalmol 132: 427-9, 2001
59. Lip PL, Belgore F, Blann AD, et al: Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment. Invest Ophthalmol Vis Sci 41: 2115-9, 2000
60. Duh EJ, Yang HS, Suzuma I, et al: Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth. Invest Ophthalmol Vis Sci 43: 821-9, 2002
61. Jablonski MM, Tombran-Tink J, Mrazek DA, et al: Pigment epithelium-derived factor supports normal Müller cell development and glutamine synthetase expression after removal of the retinal pigment epithelium. Glia 35: 14-25, 2001
62. Jonas JB, Akkoyun I, Kamppeter B, et al: Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide. Eye 19: 65-71, 2005
63. Hayashi K, Hayashi H: Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 139: 972-82, 2005
64. Chen SD, Lochhead J, Patel CK, et al: Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion. Br J Ophthalmol 88: 154-5, 2004
65. Lee H, Shah GK: Intravitreal triamcinolone as primary treatment of cystoid macular edema secondary to branch retinal vein occlusion. Retina 25: 551-5, 2005
66. Krepler K, Ergun E, Sacu S, et al: Intravitreal triamcinolone acetonide in patients with macular oedema due to branch retinal vein occlusion: a pilot study. Acta Ophthalmol Scand 83: 600-4, 2005
67. Beer PM, Bakri SJ, Singh RJ, et al: Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110: 681-6, 2003
68. Gillies MC, Simpson JM, Billson FA, et al: Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol 122: 336-40, 2004
69. Rosenfeld PJ, Fung AE, Puliafito CA: Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36: 336-9, 2005
70. Glacet-Bernard A, Coscas G, Chabanel A, et al: A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol 118: 421-9, 1994
71. Yamamoto T, Kamei M, Yokoi N, et al: Comparative effect of antiplatelet therapy in retinal vein occlusion evaluated by the particle-counting method using light scattering. Am J Ophthalmol 138: 809-17, 2004
72. Chen HC, Wiek J, Gupta A, et al: Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion. Br J Ophthalmol 82: 162-7, 1998
73. Fekrat S, Goldberg MF, Finkelstein D: Laser-induced chorioretinal venous anastomosis for non-ischemic central or branch retinal vein occlusion. Arch Ophthalmol 116: 43-52, 1998
74. Bavbek T, Yenice O, Toygar O: Problems with attempted chorioretinal venous anastomosis by laser for nonischemic CRVO and BRVO. Ophthalmologica 219: 267-71, 2005
75. Stefánsson E, Novack RL, Hatchell DL: Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 31: 284-9, 1990
76. Avunduk AM, Cetinkaya K, Kapicioolu Z, et al: The effect of posterior vitreous detachment on the prognosis of branch retinal vein occlusion. Acta Ophthalmol Scand 75: 441-2, 1997
77. Takahashi MK, Hikichi T, Akiba J, et al: Role of the vitreous and macular edema in branch retinal vein occlusion. Ophthalmic Surg Lasers 28: 294-9, 1997
78. Saika S, Tanaka T, Miyamoto T, et al: Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular edema associated with branch retinal vein occlusion: retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol 239: 729-32, 2001
79. Yamamoto S, Saito W, Yagi F, et al: Vitrectomy with or without arteriovenous adventitial sheathotomy for macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 138: 907-14, 2004
80. Osterloh MD, Charles S: Surgical decompression of branch retinal vein occlusions. Arch Ophthalmol 106: 1469-71, 1988
81. Opremcak EM, Bruce RA: Surgical decompression of branch retinal vein occlusion via arteriovenous crossing sheathotomy: a prospective review of 15 cases. Retina 19: 1-5, 1999
82. Shah GK, Sharma S, Fineman MS, et al: Arteriovenous adventitial sheathotomy for the treatment of macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 129: 104-6, 2000
83. Cahill MT, Kaiser PK, Sears JE, et al: The effect of arteriovenous sheathotomy on cystoid macular oedema secondary to branch retinal vein occlusion. Br J Ophthalmol 87: 1329-32, 2003
84. Yamaji H, Shiraga F, Tsuchida Y, et al: Evaluation of arteriovenous crossing sheathotomy for branch retinal vein occlusion by fluorescein videoangiography and image analysis. Am J Ophthalmol 137: 834-41, 2004
85. Charbonnel J, Glacet-Bernard A, Korobelnik JF, et al: Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol 242: 223-8, 2004
86. Mester U, Dillinger P: Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion. Retina 22: 740-6, 2002
87. Mason J, Feist R, White M, et al: Sheathotomy to decompress branch retinal vein occlusion: a matched control study. Ophthalmology 111: 540-5, 2004
88. Tang WM, Han DP: A study of surgical approaches to retinal vascular occlusions. Arch Ophthalmol 118: 138-43, 2000
89. García-Arumí J, Martinez-Castillo V, Boixadera A, et al: Management of macular edema in branch retinal vein occlusion with sheathotomy and recombinant tissue plasminogen activator. Retina 24: 530-40, 2004